logo
Tainted Supplements, Troubled Transactions: Social Commerce Dangers

Tainted Supplements, Troubled Transactions: Social Commerce Dangers

Forbes3 days ago
Rochelle Blease is the president of G2 Risk Solutions, a global risk management firm.
Promising easy weight loss or an enhanced appearance, influencers are driving more traffic to nutraceutical websites that sell unapproved products. The strategy works; 77% of consumers prefer influencer content over ads. In a 2025 survey, 20% of U.S. adults reported buying based on influencer recommendations, and 43% follow at least one content creator.
Beyond consumers, payment providers are also at risk. When health is at stake, regulators and card networks scrutinize sellers and the financial services that enable them.
Payment providers often lack visibility into noncompliant merchant activity. That's because traditional due diligence wasn't built for today's high-velocity social commerce, where shoppable posts and affiliate links blur the line between content and commerce. In the U.S. alone, social commerce sales are projected to exceed $100 billion in 2026.
Invisible Ingredients
Social media fosters diet and beauty trends that often promote unsafe products. In 2024, for example, the FDA issued warnings about online sales of tainted weight loss supplements. Marketed as the Mexican fruit 'tejocote,' the products were found by the FDA to contain toxic yellow oleander, which can cause severe or fatal health effects.
Tainted cosmetics are another area of concern. Through compelling visual content of before-and-after skin transformations, consumers can be guided to purchase potentially dangerous skincare. In recent years, regulators have uncovered products marketed as over-the-counter 'skin lighteners' that contain undisclosed ingredients, including hydroquinone and mercury. Consumers exposed to these products have experienced mercury poisoning, rashes and permanent skin discoloration.
These examples represent a fraction of the murky world of social commerce, where every regulatory alert is a red flag that payment providers can't ignore.
Payment Providers' Responsibility
Viral trends and influencer endorsements introduce a highly dynamic risk vector into the payments industry. Payment providers are expected to vet and monitor their merchants for risky behaviors, including the sale of tainted supplements. In the view of card networks and regulators, facilitating payments ultimately helps dangerous merchants—even if the provider isn't aware of a merchant's illicit actions.
Obtaining such awareness can be tricky. Merchants that look benign may be selling violative or illegal products that pose health dangers. Some merchants go to great lengths to hide the true nature of their businesses, using fake shell sites to pass due diligence checks. Others may leave vital information off their payment account applications, such as affiliated social commerce sites, sales pages or merchant category codes that would place them in high-risk categories.
A single viral post can trigger thousands of transactions, making visibility gaps costly for payment providers. Card networks can impose significant fines for enabling illicit transactions. What's more, card network action often prompts additional scrutiny from regulators.
Managing Merchant Risk
To mitigate risks, payment providers need a responsive framework that includes deeper onboarding intelligence and continuous monitoring. A programmatic, data-driven approach can surface red flags.
Here are five actionable steps payment providers should take:
Traditional underwriting is not enough in a market where a merchant can shift product lines, ownership or marketing tactics in a matter of hours. Acquiring banks should expand initial due diligence to include beneficial ownership verification, adverse media screening and website traffic analysis.
More importantly, they should adopt a scheduled refresh process to keep that data current. Doing so can help spot risk indicators before they turn into enforcement actions. In an industry where reputational fallout travels faster than compliance updates, reactive vetting is no longer defensible.
Once a merchant is onboarded, too many acquirers rely solely on transaction data to spot fraud. That's no longer enough. The front end of many risky supplement sellers is a slick landing page optimized for conversion—one that may change copy, imagery and claims overnight.
By incorporating automated web-crawling, payment providers can quickly flag risky language like 'FDA-approved' or 'clinically proven.' When a supplement merchant updates its marketing to include aggressive health claims, it's often a sign of accelerating risk.
Banks are not labs and shouldn't try to act like them. However, they can make powerful use of existing regulatory data. Government agencies issue a steady stream of alerts, many of which are specific to product brands, ingredients and merchant URLs.
By ingesting and cross-referencing this data against their own merchant portfolio, payment providers can quickly flag when a merchant is under regulatory scrutiny. It's a simple but often overlooked method for maintaining awareness of known bad actors—one that doesn't require waiting for a spike in chargebacks to signal trouble.
Payment providers have one data stream that regulators and card networks don't: real-time transaction trends. Used correctly, that stream becomes a powerful source of early detection.
Unusual spikes in high-ticket transactions, increases in cross-border routing or refund patterns that don't match the merchant's stated model are signs that something may be amiss. Sophisticated acquirers are now using AI-assisted tools to benchmark merchants against known fraud patterns, surfacing anomalies before they become liabilities.
When violations do occur—whether flagged internally or raised by a network—speed and structure matter. Leading risk teams are developing standardized systems that capture digital evidence (like screenshots, product descriptions and influencer endorsements) and route that data through tiered workflows.
Depending on the severity of the issue, these may trigger outreach for clarification, a corrective action plan or merchant termination. Crucially, this approach generates an audit trail that demonstrates to networks or regulators that the bank took reasonable and timely steps. In today's climate, that paper trail can mean the difference between resolving an issue and becoming part of an enforcement action.
The Path Forward: Coordinated Intelligence, Not Just Controls
Modern risk management is no longer rooted in static compliance. It's driven by real-time intelligence strategies that surface red flags quickly. The opportunity lies in integration: Connecting onboarding, monitoring, regulatory data and transaction signals into a unified view of merchant behavior.
Forbes Technology Council is an invitation-only community for world-class CIOs, CTOs and technology executives. Do I qualify?
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

3 simple ways to spot fake weight loss jabs after Mounjaro price hike
3 simple ways to spot fake weight loss jabs after Mounjaro price hike

Yahoo

time8 minutes ago

  • Yahoo

3 simple ways to spot fake weight loss jabs after Mounjaro price hike

With the price of Mounjaro set to almost triple in the UK, there are fears more and more people will turn to counterfeits. A former Big Brother star has said she "thought she was going to die" after taking a "fake" weight loss jab amid fears of a spike in black market demand as the price of Mounjaro is due to almost triple in the UK. Aisleyne Horgan Wallace told Good Morning Britain she suffered an adverse reaction when she bought the jab online. She said she temporarily lost her sight in one eye, suffered extreme vomiting and was in excruciating pain from the jab. Wallace said she took several doses before one left her bedridden and in and out of consciousness for several days. She has now warned about the dangers of counterfeit jabs after admitting it was a "foolish thing to do." Their high cost and limited availability have led to a flourishing black market for fake jabs. The National Pharmacy Association has warned about the risk of buying the jabs online without consulting a medical professional. In May, ITV News analysed some fake jabs they acquired at a "skinny jab party" and found they contained none of the active ingredients that contribute to weight loss. But there are fears that black market problems will get worse before they get better as Mounjaro's producer, Eli Lilly, is set to increase prices in the UK. Eli Lilly has said it will increase its prices in the UK from September after Donald Trump ramped up pressure on US pharmaceutical companies. The US president has promised to stop the disparity between what Americans pay for US-produced drugs compared to other countries, which often pay far less. The Rand Corporation think tank has said that US consumers pay three times more for drugs than in other developed countries. Trump has urged companies to close the gap and has threatened reprisals for those who do not do it voluntarily. There are fears that, rather than lowering the US price, drug companies will just raise their global price to meet Trump's demands, as appears to be the case with Eli Lilly. How much is Mounjaro increasing? Eli Lilly has said it will increase the price of the drug from September by 170%. A month's supply of the highest dose is rising from £122 to £330. Eli Lilly said the NHS would not pay for a higher price, so it will still be prescribed for people with obesity and type 2 diabetes. It will be the people who buy the jab privately through pharmacies or online stores that pay the higher price. The company has said private healthcare providers will be able to negotiate their own prices for purchasing the drug. Mounjaro is seen as the best weight-loss drug available by some, although Wegovy, made by Danish company Novodisk, has seen a huge surge in demand as a result of the price rises. A trial comparing the drugs found that people who took Mounjaro over 72 weeks lost 22.8kg compared to 15kg for people who took Wegovy. This has all led to a surge in people being uncompromising in their desire for Mounjaro and has led to many looking for alternative ways to secure their jabs. Medical professionals warn about people turning to counterfeits The price increase has led to people purchasing as many Mounjaro jabs as possible, but medical professionals have warned to be careful where you buy them from. Professor Claire Anderson, president of the Royal Pharmacist Society (RPS), told the Independent: "Counterfeit medicines from unregulated sources pose serious health risks - they can contain incorrect doses, harmful substances or no active ingredient at all." Jason Murphy, Head of Pharmacy at online retailer Chemist4U, said: "With the recent price hikes, we're likely to see more and more people turning to unregulated sellers because the medication may be cheaper. "This is extremely unsafe as many of these sources distribute counterfeit versions of Mounjaro, which pose serious risks to your health." The National Pharmacy Association has urged the government to improve regulation around online purchase of weight loss jabs to ensure people get the proper medical advice when buying them. How to spot fake weight loss jabs Chemist4U said there were three main identifiers to suggest a jab is fake. First, cost is a big one, the price of these jabs is set at certain points, with most retailers selling them at only a small profit. If you see one for considerably cheaper than normal, ask yourself how the seller got this from the manufacturer cheaper than large high street chains did. Secondly, currently in the UK Wegovy and Mounjaro are prescription-only medicines and can only be issued after a consultation. You can buy them from stores like Boots or Asda Pharmacy, but they will require a medical consultation first. If a vendor is selling them without this step, then you should steer clear of buying them. Finally, they will also look different. Chemist4U says "the materials used for real pens feel solid and well made, whereas a fake pen is likely to feel cheap, flimsy and have more obvious flaws like uneven colouring, rough edges or loose parts". They also point out that the real pens each have a unique serial number, whereas fake ones will not have one or a fake one.

Mizuho Raises Boston Scientific (BSX) Price Target as Robotics and Devices Drive Growth
Mizuho Raises Boston Scientific (BSX) Price Target as Robotics and Devices Drive Growth

Yahoo

time8 minutes ago

  • Yahoo

Mizuho Raises Boston Scientific (BSX) Price Target as Robotics and Devices Drive Growth

Boston Scientific Corporation (NYSE:BSX) ranks among the . Mizuho kept its Outperform rating on Boston Scientific Corporation (NYSE:BSX), and increased its price target for the medical device maker from $130 to $140 on July 24. The firm reported that the global recall of the ACURATE transcatheter aortic valve replacement (TAVR) system in the second half of the year was expected to be compensated by solid performance in Boston Scientific's FARAPULSE and WATCHMAN product lines. While Boston Scientific Corporation (NYSE:BSX) has no plans to re-engineer the ACURATE valve, putting it 'at square one in the TAVR space,' the company is still on track to acquire clearances for FARAPULSE in China and Japan before the end of the year, according to Mizuho's research. Boston Scientific Corporation (NYSE:BSX) is a global leader in the manufacture of medical devices, including stents, brain stimulation systems, heart monitors, and catheters. A leading name in robotics, the company has made great strides in the humanoid aspect of the industry with its two-legged Atlas robot. While we acknowledge the potential of BSX to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than BSX and that has 100x upside potential, check out our report about this cheapest AI stock. READ NEXT: and . Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Infographic: How Doctors Feel About Labor Unions
Infographic: How Doctors Feel About Labor Unions

Medscape

time10 minutes ago

  • Medscape

Infographic: How Doctors Feel About Labor Unions

A substantial share of physicians in a Medscape survey felt positively about the trend toward union representation in their ranks in the US. But they were somewhat more skeptical about how effective unions had been in representing doctors' interests, and they felt fellow physicians and patients might see unions in a less favorable light. This infographic presents key insights from a new report on the much-discussed topic of union organization of doctors. To learn more, check out the Medscape Future of Physician Unions Report 2025. Medscape Future of Physician Unions Report 2025

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store